Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment.

Literature DB >> 19300874

Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment.

P J Visser¹.

Abstract

Entities: Disease

Mesh：

Substances：
Biomarkers

Year: 2009 PMID： 19300874 DOI： 10.1007/s12603-009-0037-6

Source DB: PubMed Journal: J Nutr Health Aging ISSN： 1279-7707 Impact factor: 4.075

× No keyword cloud information.

23 in total

1. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.

Authors: Gene E Alexander; Kewei Chen; Pietro Pietrini; Stanley I Rapoport; Eric M Reiman
Journal: Am J Psychiatry Date: 2002-05 Impact factor: 18.112

Review 2. Clinical trials in mild cognitive impairment: lessons for the future.

Authors: V Jelic; M Kivipelto; B Winblad
Journal: J Neurol Neurosurg Psychiatry Date: 2005-11-23 Impact factor: 10.154

3. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.

Authors: Miroslaw Brys; Elizabeth Pirraglia; Kenneth Rich; Sindre Rolstad; Lisa Mosconi; Remigiusz Switalski; Lidia Glodzik-Sobanska; Susan De Santi; Ray Zinkowski; Pankaj Mehta; Domenico Pratico; Leslie A Saint Louis; Anders Wallin; Kaj Blennow; Mony J de Leon
Journal: Neurobiol Aging Date: 2007-09-24 Impact factor: 4.673

4. PET imaging of amyloid deposition in patients with mild cognitive impairment.

Authors: Anton Forsberg; Henry Engler; Ove Almkvist; Gunnar Blomquist; Göran Hagman; Anders Wall; Anna Ringheim; Bengt Långström; Agneta Nordberg
Journal: Neurobiol Aging Date: 2007-05-11 Impact factor: 4.673

5. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia.

Authors: J T O'Brien; S Paling; R Barber; E D Williams; C Ballard; I G McKeith; A Gholkar; W R Crum; M N Rossor; N C Fox
Journal: Neurology Date: 2001-05-22 Impact factor: 9.910

6. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Authors: Henry Engler; Anton Forsberg; Ove Almkvist; Gunnar Blomquist; Emma Larsson; Irina Savitcheva; Anders Wall; Anna Ringheim; Bengt Långström; Agneta Nordberg
Journal: Brain Date: 2006-07-19 Impact factor: 13.501

Review 7. PET imaging of amyloid in Alzheimer's disease.

Authors: Agneta Nordberg
Journal: Lancet Neurol Date: 2004-09 Impact factor: 44.182

8. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria.

Authors: P J Visser; F R J Verhey
Journal: Psychol Med Date: 2007-04-24 Impact factor: 7.723

Review 9. CSF markers for incipient Alzheimer's disease.

Authors: Kaj Blennow; Harald Hampel
Journal: Lancet Neurol Date: 2003-10 Impact factor: 44.182

10. Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

Authors: Henrik Zetterberg; Mona Pedersen; Karin Lind; Maria Svensson; Sindre Rolstad; Carl Eckerström; Steinar Syversen; Ulla-Britt Mattsson; Christina Ysander; Niklas Mattsson; Arto Nordlund; Hugo Vanderstichele; Eugeen Vanmechelen; Michael Jonsson; Ake Edman; Kaj Blennow; Anders Wallin
Journal: J Alzheimers Dis Date: 2007-11 Impact factor: 4.472

3 in total